{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:58:53Z","timestamp":1762981133858,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ejca.2021.03.030","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T21:45:43Z","timestamp":1617313543000},"page":"232-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER)"],"prefix":"10.1016","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8065-9635","authenticated-orcid":false,"given":"David","family":"Tougeron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2729-9420","authenticated-orcid":false,"given":"Maxime","family":"Hentzien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Seitz-Polski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firouze","family":"Bani-Sadr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Bourhis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Ducreux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Gaujoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7604-4964","authenticated-orcid":false,"given":"Philippe","family":"Gorphe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Guiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kh\u00ea","family":"Hoang-Xuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Lecomte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Li\u00e8vre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Louvet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e9on","family":"Maggiori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Mansi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Michel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Am\u00e9lie","family":"Servettaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliette","family":"Thariat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virgine","family":"Westeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8834-6927","authenticated-orcid":false,"given":"Thomas","family":"Aparicio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7190-120X","authenticated-orcid":false,"given":"Jean-Yves","family":"Blay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Bouch\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2021.03.030_bib1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejca.2020.09.035","article-title":"Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: a French nationwide cohort study (GCO-002 CACOVID-19)","volume":"141","author":"Li\u00e8vre","year":"2020","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejca.2021.03.030_bib2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejca.2020.05.028","article-title":"High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR","volume":"135","author":"Assaad","year":"2020","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejca.2021.03.030_bib3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejca.2020.09.028","article-title":"A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19","volume":"141","author":"Yeked\u00fcz","year":"2020","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejca.2021.03.030_bib4","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1056\/NEJMc2031670","article-title":"Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer","volume":"383","author":"Aydillo","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2021.03.030_bib5","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.annonc.2020.04.475","article-title":"Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19","volume":"31","author":"Solodky","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2021.03.030_bib6","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1002\/onco.13578","article-title":"Dramatic changes in oncology care pathways during the COVID-19 pandemic: the French ONCOCARE-COV study","volume":"26","author":"Brugel","year":"2020","journal-title":"Oncol"},{"key":"10.1016\/j.ejca.2021.03.030_bib7","doi-asserted-by":"crossref","first-page":"m4087","DOI":"10.1136\/bmj.m4087","article-title":"Mortality due to cancer treatment delay: systematic review and meta-analysis","volume":"371","author":"Hanna","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2021.03.030_bib8","first-page":"31050","article-title":"Management of digestive cancers during the COVID-19 second wave: a French intergroup point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR)","volume":"S1590\u20138658","author":"Tougeron","year":"2020","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ejca.2021.03.030_bib9","doi-asserted-by":"crossref","first-page":"619e21","DOI":"10.1016\/S1470-2045(20)30204-7","article-title":"The official French guidelines to protect patients with cancer against SARS-CoV-2 infection","volume":"21","author":"You","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2021.03.030_bib10","first-page":"100769","article-title":"Proposals for managing patients with thoracic malignancies during COVID-19 pandemic","volume":"78","author":"Girard","year":"2020","journal-title":"Respir Med Res"},{"key":"10.1016\/j.ejca.2021.03.030_bib11","doi-asserted-by":"crossref","first-page":"104734","DOI":"10.1016\/j.oraloncology.2020.104734","article-title":"Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic","volume":"107","author":"Chaves","year":"2020","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ejca.2021.03.030_bib12","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.annonc.2020.03.308","article-title":"French Sarcoma Group proposals for management of sarcoma patients during the COVID-19 outbreak","volume":"31","author":"Penel","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2021.03.030_bib13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejca.2020.11.037","article-title":"Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era","volume":"144","author":"Rodriguez-Freixinos","year":"2021","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejca.2021.03.030_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2021.01.068","article-title":"The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate","author":"Garassino","year":"2021","journal-title":"Monitor. Educate. Ann Oncol."},{"key":"10.1016\/j.ejca.2021.03.030_bib15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1158\/2159-8290.CD-20-1817","article-title":"Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited","volume":"11","author":"Ribas","year":"2021","journal-title":"Canc Discov"},{"unstructured":"American society of clinical oncology. https:\/\/www.asco.org\/asco-coronavirus-resources\/covid-19-patient-care-information\/covid-19-vaccine-patients-cancer, accessed February 2021.","key":"10.1016\/j.ejca.2021.03.030_bib16"},{"key":"10.1016\/j.ejca.2021.03.030_bib18","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ejca.2021.03.030_bib19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejca.2020.08.013","article-title":"Immunological features of coronavirus disease 2019 in patients with cancer","volume":"139","author":"Thibaudin","year":"2020","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejca.2021.03.030_bib20","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2021.03.030_bib21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2021.03.030_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2021.03.030_bib23","article-title":"Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia","volume":"S0140\u20136736","author":"Logunov","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2021.03.030_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.annonc.2020.10.473","article-title":"Seroconversion in patients with cancer and oncology health care workers infected by SARS-CoV-2","volume":"32","author":"Marra","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2021.03.030_bib25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/archinte.165.3.274","article-title":"Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions : the PRISMA study","volume":"165","author":"Hak","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejca.2021.03.030_bib26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2021.03.030_bib27","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jama.2021.0600","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine","volume":"23","author":"Shimabukuro","year":"2021","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ejca.2021.03.030_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.critrevonc.2019.05.003","article-title":"State of the art about influenza vaccination for advanced cancer patients receiving immune checkpoint inhibitors: when common sense is not enough","volume":"139","author":"Bersanelli","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejca.2021.03.030_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(20)31182-X","article-title":"Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2021.03.030_bib30","article-title":"SARS-CoV-2 vaccination and phase 1 cancer clinical trials","volume":"S1470\u20132045","author":"Yap","year":"2021","journal-title":"Lancet Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804921001970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804921001970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:31:54Z","timestamp":1760733114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804921001970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":29,"alternative-id":["S0959804921001970"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2021.03.030","relation":{},"ISSN":["0959-8049"],"issn-type":[{"type":"print","value":"0959-8049"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2021.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}